Sign inGet started

Talamo Joseph

Insider CIK 1524547 · INTS Chief Financial Officer · NBS See Remarks

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
INTS INTENSITY THERAPEUTICS, IN A Award deriv2026-07-162026-07-2034,000— $034,000SEC↗
INTS INTENSITY THERAPEUTICS, IN A Award2026-06-302026-07-011,093$3.49 $3.8K2,239SEC↗
INTS INTENSITY THERAPEUTICS, IN A Award2025-12-312026-01-0514,482$0.26 $3.8K28,661SEC↗
INTS INTENSITY THERAPEUTICS, IN A Award2025-06-302025-07-0214,179$0.26 $3.7K14,179SEC↗
INTS INTENSITY THERAPEUTICS, IN A Award deriv2025-05-022025-05-06300,000— $0300,000SEC↗
INTS INTENSITY THERAPEUTICS, IN A Award deriv2024-10-212024-10-23427,379— $0427,379SEC↗
INTS INTENSITY THERAPEUTICS, IN A Award deriv2023-12-112023-12-1280,000— $080,000SEC↗
CLBS CALADRIUS BIOSCIENCES, INC F Tax w/h2020-01-142020-01-152,190$3.38 $7.4K59,644SEC↗
CLBS CALADRIUS BIOSCIENCES, INC A Award deriv2020-01-132020-01-1529,000— $029,000SEC↗
CLBS CALADRIUS BIOSCIENCES, INC F Tax w/h2020-01-132020-01-152,601$3.28 $8.5K61,834SEC↗
CLBS CALADRIUS BIOSCIENCES, INC A Award2020-01-132020-01-1519,000— $064,435SEC↗
CLBS CALADRIUS BIOSCIENCES, INC F Tax w/h2020-01-082020-01-091,821$2.83 $5.2K45,435SEC↗
CLBS CALADRIUS BIOSCIENCES, INC A Award deriv2019-01-142019-01-1624,000— $024,000SEC↗
CLBS CALADRIUS BIOSCIENCES, INC F Tax w/h2019-01-142019-01-162,159— $047,256SEC↗
CLBS CALADRIUS BIOSCIENCES, INC A Award2019-01-142019-01-1616,000— $049,415SEC↗
CLBS CALADRIUS BIOSCIENCES, INC F Tax w/h2019-01-082019-01-101,795$4.64 $8.3K33,415SEC↗
CLBS CALADRIUS BIOSCIENCES, INC F Tax w/h2018-06-202018-06-216,407$8.64 $55.4K35,210SEC↗
CLBS CALADRIUS BIOSCIENCES, INC A Award2018-06-202018-06-2113,300$8.64 $114.9K41,617SEC↗
CLBS CALADRIUS BIOSCIENCES, INC A Award deriv2018-04-062018-04-1013,300— $013,300SEC↗
CLBS CALADRIUS BIOSCIENCES, INC A Award deriv2018-01-082018-01-1020,000— $020,000SEC↗
CLBS CALADRIUS BIOSCIENCES, INC F Tax w/h2018-01-082018-01-101,803— $028,317SEC↗
CLBS CALADRIUS BIOSCIENCES, INC A Award2018-01-082018-01-1013,300— $030,120SEC↗
CLBS Caladrius Biosciences, Inc F Tax w/h2017-05-182017-05-225,982$5.13 $30.7K15,619SEC↗
CLBS Caladrius Biosciences, Inc F Tax w/h2017-04-252017-04-27214$4.74 $1.0K21,601SEC↗
CLBS Caladrius Biosciences, Inc F Tax w/h2017-01-252017-01-27239$3.87 $92521,812SEC↗
CLBS Caladrius Biosciences, Inc A Award deriv2017-01-092017-01-1120,000— $020,000SEC↗
CLBS Caladrius Biosciences, Inc F Tax w/h2017-01-092017-01-111,672$3.54 $5.9K22,051SEC↗
CLBS Caladrius Biosciences, Inc A Award2017-01-092017-01-1113,300— $023,723SEC↗
CLBS Caladrius Biosciences, Inc F Tax w/h2016-10-252016-11-10176$4.12 $72510,423SEC↗
CLBS Caladrius Biosciences, Inc A Award deriv2016-09-292016-09-3013,377— $013,377SEC↗
CLBS Caladrius Biosciences, Inc F Tax w/h2016-07-252016-08-12176$5.40 $95010,599SEC↗
CLBS Caladrius Biosciences, Inc F Tax w/h2016-04-252016-05-021,714$0.68 $1.2K101,651SEC↗
CLBS Caladrius Biosciences, Inc A Award deriv2016-01-252016-01-27125,000— $0125,000SEC↗
CLBS Caladrius Biosciences, Inc F Tax w/h2016-01-252016-01-278,032$0.63 $5.1K103,365SEC↗
CLBS Caladrius Biosciences, Inc A Award2016-01-252016-01-2776,000— $0111,397SEC↗
CLBS Caladrius Biosciences, Inc A Award2015-06-302015-07-021,574$1.59 $2.5K32,413SEC↗
NBS NeoStem, Inc. A Award2015-06-022015-06-0422,500— $030,839SEC↗
NBS NeoStem, Inc. A Award deriv2015-01-022015-01-0230,000— $030,000SEC↗
NBS NeoStem, Inc. A Award2014-12-312015-01-02710$3.20 $2.3K8,339SEC↗
NBS NeoStem, Inc. A Award deriv2014-08-012014-08-0125,000— $025,000SEC↗
NBS NeoStem, Inc. A Award2014-08-012014-08-016,303— $07,629SEC↗
NBS NeoStem, Inc. A Award2014-06-302014-07-01411$5.54 $2.3K1,326SEC↗
NBS NeoStem, Inc. A Award deriv2014-01-022014-01-0335,000— $035,000SEC↗
NBS NeoStem, Inc. A Award2013-12-312014-01-03454$4.85 $2.2K915SEC↗
NBS NeoStem, Inc. A Award deriv2013-01-022013-01-04225,000— $0225,000SEC↗
NBS NeoStem, Inc. A Award deriv2012-01-042012-01-0675,000— $075,000SEC↗